NUECLEAR HEALTHCARE LIMITED - Key Persons

Positron Emission Tomography-Computed Tomography (PET-CT) detects bodily changes at cellular and molecular level to identify early onset of diseases, like cancer. PET-CT is more efficient than other imaging tests. PET provides functional data and CT provides quality anatomical images. PET-CT uses small amounts of radioactive materials called radiotracers or dye, a special camera and a computer for accurate diagnosis. Commonly used dyes include 18F-FDG, 68Ga-PSMA, 18F-DOPA and 18F-PSMA. PET-CT is recommended for staging the disease, understanding therapy response, detecting recurrence early and routine follow-ups after treatment. At Nueclear, we provide reliable high-quality PET-CT imaging services to cancer patients across India at an affordable cost.

Job Titles:

• Chairman, Managing Director & CEO of Thyrocare

Mr Rahul Guha is the Chairman, Managing Director & CEO of Thyrocare and Nueclear Healthcare Limited. Post graduate from IIM Bangalore, Rahul has a professional experience of 21 years in the healthcare industry. His journey began with part-time work at CBT Group TCS into product development. He then assumed key roles, such as Chief Technology Officer at ValuePay.com, where he led product development in the competitive US market. His most significant career highlight is his long tenure at Boston Consulting Group (BCG). Over 17 years, Rahul made substantial contributions as a Senior Partner and Lead in the Healthcare & Life Sciences Practice in India.